Browsing by Author Tselepis, A. D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 255  next >
TitleAuthor(s)Issue date
1-0-Alkyl-2-Acetyl-Sn-Glyceryl-3-Phosphorylcholine (Paf) Is a Minor Lipid Component in Tetrahymena-Pyriformis CellsLekka, M.; Tselepis, A. D.; Tsoukatos, D.24-Nov-2015
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemiaKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Nakou, E. S.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Acute and long-term antiplatelet therapyPapathanasiou, A. I.; Goudevenos, J. A.; Mikhailidis, D. P.; Tselepis, A. D.24-Nov-2015
Acute infection with Epstein-Barr virus is associated with atherogenic lipid changesApostolou, F.; Gazi, I. F.; Lagos, K.; Tellis, C. C.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M.24-Nov-2015
Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysisTentolouris, N.; Boutati, E.; Karambakalis, N.; Perea, D.; Tselepis, A. D.; Tsoukala, C.; Kyriaki, D.; Lourida, E.; Anastasopoulou, I.; Karafoullidou, A.; Raptis, S. A.; Katsilambros, N.24-Nov-2015
Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis (vol 15, pg 6, 2005)Tentolouris, N.; Boutati, E.; Karambakalis, N.; Perrea, D.; Tselepis, A. D.; Tsoukala, C.; Kyriaki, D.; Lourida, E.; Anastasopoulou, I.; Karafoullidou, A.; Raptis, S. A.; Katsilambros, N.24-Nov-2015
Alterations in plasma oxidative stress markers after laparoscopic operations of the upper and lower abdomenGlantzounis, G. K.; Tsimaris, I.; Tselepis, A. D.; Thomas, C.; Galaris, D. A.; Tsimoyiannis, E. C.24-Nov-2015
Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic SyndromeLagos, K. G.; Filippatos, T. D.; Tsimihodimos, V.; Gazi, I. F.; Rizos, C.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Alterations in uric acid serum levels in laparoscopic procedures of upper abdomenGlantzounis, G. K.; Tsimaris, I.; Vasakos, S.; Tambaki, A. P.; Tselepis, A. D.; Galaris, D.; Tsimoyiannis, E. C.24-Nov-2015
Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysisLiberopoulos, E. N.; Papavasiliou, E.; Miltiadous, G. A.; Cariolou, M.; Siamopoulos, K. C.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemiaTsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemiaTsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Amphipathic alpha-helical peptide models of apolipoprotein A-I inhibit LDL oxidation and inactivation of PAF-acetyl-hydrolase in vitroPetraki, M.; Alexopoulos, C. H.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Tselepis, A. D.24-Nov-2015
Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemiaTsouli, S. G.; Kiortsis, D. N.; Xydis, V.; Argyropoulou, M. I.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Antioxidant effects of alpha-helix apolipoprotein A-I peptide models in relation to their structurePetraki, M.; Harilogis, K.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Tselepis, A. D.24-Nov-2015
Antioxidant effects of lipophilic derivatives of flavonol glucosidesPetraki, M. P.; Kontogianni, A.; Spyrou, A. A.; Kolisis, F. N.; Elisaf, M.; Stamatis, H.; Tselepis, A. D.24-Nov-2015
The Antiplatelet and Antithrombotic Actions of StatinsMitsios, J. V.; Papathanasiou, A. I.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015
Antiplatelet Efficacy of Long-Term Treatment With Clopidogrel Besylate in Patients With a History of Acute Coronary Syndrome: Comparison With Clopidogrel Hydrogen SulfateTsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Ntalas, I. V.; Goudevenos, I. A.; Tselepis, A. D.24-Nov-2015
Apolipoprotein A-I amphipathic alpha-helical peptide models: effect on LDL oxidation in vitroSakarellos-Daitsiotis, M.; Alexopoulos, C.; Tambaki, A.; Harilogis, K.; Tselepis, A. D.; Sakarellos, C.24-Nov-2015
Apolipoprotein A-I peptide models as probes to formulate potential inhibitors of the low-density lipoprotein oxidationDarvari, M. I.; Petraki, M. P.; Tellis, C.; Harilogis, K.; Tselepis, A. D.; Sakarellos-Daitsiotis, M.24-Nov-2015